Drug profile · INN
desvenlafaxine fumarate
DESVENLAFAXINE
desvenlafaxine fumarate (DESVENLAFAXINE) is a norepinephrine transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — desvenlafaxine fumarate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 4
- Data quality
- 0.89
Quick answer
desvenlafaxine fumarate (DESVENLAFAXINE) is a norepinephrine transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter inhibitor
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is desvenlafaxine fumarate?
desvenlafaxine fumarate (DESVENLAFAXINE) is a norepinephrine transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for desvenlafaxine fumarate?
DESVENLAFAXINE is a marketed brand name for desvenlafaxine fumarate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of desvenlafaxine fumarate?
desvenlafaxine fumarate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.